These rankings are based on data from September 2026
Company
DoMore Diagnostics
Years in business
- 5
Number of employees
- 2-10 employees
Country
- Norway
DoMore Diagnostics develops AI-powered digital pathology tools that help predict cancer outcomes and support more personalized treatment decisions, especially in colorectal cancer. Its Histotype Px® technology aims to improve prognosis accuracy and reduce over- and undertreatment in clinical care.
API Availability
- Unknown
Pricing
unknown
Ranking position over time
October 2025 - September 2026
#17,193
Best rank
#20,626
Lowest rank
12-month trend
#16,521
Best rank
#20,770
Lowest rank
12-month trend
Position of DoMore Diagnostics on sub rankings
September 2026
Industries
health & sports
it
research & development
Integrations
digital pathology systems
hospital information systems
laboratory information systems
Security protocols
gdpr
L3 category names
Company
DoMore Diagnostics
Years in business
- 5
Number of employees
- 2-10 employees
Country
- Norway
- OpenAI’s new business feature: a death blow to AI visibility trackers?
- AI Product Image Generators: The Most Popular Solutions Reshaping E-Commerce Visuals
- 5 New AI Tools: From the dentist's front desk to the law firm's intake
- Persona Development: The Most Popular AI Tools for Building Your Ideal Customer
- Behind the scenes: Better search, ranking history and faster tool listings
Insights
